Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rofecoxib and Naproxen in Alzheimer's Disease
NCT00004845Phase 3Completed
- Sponsor
- National Institute on Aging
- Primary completion
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rofecoxib, naproxen in Alzheimer's disease (AD), sponsored by National Institute on Aging. Status: completed.
02
Drugs
rofecoxibnaproxen
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00004845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004845.